BECTON, DICKINSON AND COMPANY

(BDX)
  Report
Real-time Estimate Cboe BZX  -  02:32 2022-07-06 pm EDT
247.98 USD   +0.02%
09:05aBecton, Dickinson - BD Names Rishi Grover as Chief Integrated Supply Chain Officer
AQ
09:05aBecton, Dickinson - BD Issues 2021 ESG Report
AQ
07/05Becton Dickinson Appoints Rishi Grover as Chief Integrated Supply Chain Officer
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Babson Diagnostics, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

05/11/2022 | 06:50am EDT

Babson Diagnostics and BD (Becton, Dickinson and Company) announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing. Since 2019, the two companies have collaborated to create a capillary blood collection and testing system, now in advanced development, to enable laboratory-quality, small-volume capillary blood collection at retail settings by team members with no previous experience in blood collection. Plans under the expanded agreement include continuing research and development to enable self-collection, mobile services and at-home collection. Babson and BD also will expand the types of blood tests that are possible through small-volume blood collection beyond primary care-oriented tests, and they also plan to develop diagnostic tests for pediatric use. Over this long-term collaboration, Babson and BD are advancing development of the blood testing ecosystem, which includes BD's next generation capillary collection technology and Babson's proprietary automated sample-handling and analytical technologies. These have been designed to work together to enable blood testing that requires only one-tenth the sample volume of traditional venipuncture methods without sacrificing quality, accuracy, or the number and types of tests that are possible.


© S&P Capital IQ 2022
All news about BECTON, DICKINSON AND COMPANY
09:05aBecton, Dickinson - BD Names Rishi Grover as Chief Integrated Supply Chain Officer
AQ
09:05aBecton, Dickinson - BD Issues 2021 ESG Report
AQ
07/05Becton Dickinson Appoints Rishi Grover as Chief Integrated Supply Chain Officer
MT
07/05BD Names Rishi Grover as Chief Integrated Supply Chain Officer
PR
07/05Becton, Dickinson and Company Announces Management Changes
CI
07/05Evercore ISI Adjusts Price Target on Becton Dickinson and Co. to $265 From $300, Keeps ..
MT
07/05BD Issues 2021 ESG Report
PR
06/30Becton, Dickinson Unveils Combination Assay for COVID-19, Other Respiratory Viruses
MT
06/30BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Viru..
PR
06/30Becton, Dickinson and Company Launches Combination Test for COVID-19, Influenza A/B and..
CI
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2022 18 674 M - -
Net income 2022 1 770 M - -
Net Debt 2022 13 463 M - -
P/E ratio 2022 38,1x
Yield 2022 1,54%
Capitalization 70 676 M 70 676 M -
EV / Sales 2022 4,51x
EV / Sales 2023 4,26x
Nbr of Employees 75 000
Free-Float 77,5%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 247,93 $
Average target price 277,58 $
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Christopher J. DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY0.88%70 676
ABBOTT LABORATORIES-22.34%191 378
MEDTRONIC PLC-12.53%120 235
BAXTER INTERNATIONAL INC.-23.82%32 926
HOYA CORPORATION-31.18%31 359
DEXCOM, INC.-41.55%30 796